Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenwen Bi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Virology|June 23, 2022
Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its VariantsWenwen Bi, Guilin Chen, Bobo Dang
International Journal of Molecular Sciences|June 26, 2025
A Dual-Targeting Peptide Inhibitor Simultaneously Blocking Viral Attachment and Membrane Fusion for Broad-Spectrum Inhibition of SARS-CoV-2Wenwen Bi, Tao Zhu, Yawen Xu, et al.
Antiviral Research|August 30, 2025
An engineered chimeric ACE2-HR2 peptide exhibits potent and broad-spectrum activity against SARS-CoV-2 variantsWenwen Bi, Tao Zhu, Yawen Xu, et al.
Biomed Research International|February 11, 2015
Receptor binding domain based HIV vaccinesHuan Liu, Wenwen Bi, Qian Wang, et al.
Bioprocess and Biosystems Engineering|March 7, 2023
Efficient bio-production of glutaric acid by a metabolically engineered Escherichia coli LQ-1 based on a novel nitrogen source feeding strategyWenwen Bi, Chen Chen, Tiantian Wang, et al.
Sensors (Basel, Switzerland)|May 28, 2022
Rapid Optical Biosensing of SARS-CoV-2 Spike Proteins in Artificial SamplesYing Tao, Sumin Bian, Pengbo Wang, et al.
Journal of Virology|April 24, 2015
Nonneutralizing Antibodies Induced by the HIV-1 gp41 NHR Domain Gain Neutralizing Activity in the Presence of the HIV Fusion Inhibitor Enfuvirtide: a Potential Therapeutic Vaccine StrategyQian Wang, Wenwen Bi, Xiaojie Zhu, et al.
Cell Reports. Medicine|February 10, 2024
An enhanced broad-spectrum peptide inhibits Omicron variants in vivoWenwen Bi, Kaiming Tang, Guilin Chen, et al.
Optics Express|October 7, 2021
Wavelength-switchable ultra-narrow linewidth fiber laser enabled by a figure-8 compound-ring-cavity filter and a polarization-managed four-channel filterTing Feng, Da Wei, Wenwen Bi, et al.
Plos Pathogens|December 6, 2019
IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodiesWenwen Bi, Wei Xu, Liang Cheng, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Virology|June 23, 2022
Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its VariantsWenwen Bi, Guilin Chen, Bobo Dang
International Journal of Molecular Sciences|June 26, 2025
A Dual-Targeting Peptide Inhibitor Simultaneously Blocking Viral Attachment and Membrane Fusion for Broad-Spectrum Inhibition of SARS-CoV-2Wenwen Bi, Tao Zhu, Yawen Xu, et al.
Antiviral Research|August 30, 2025
An engineered chimeric ACE2-HR2 peptide exhibits potent and broad-spectrum activity against SARS-CoV-2 variantsWenwen Bi, Tao Zhu, Yawen Xu, et al.
Biomed Research International|February 11, 2015
Receptor binding domain based HIV vaccinesHuan Liu, Wenwen Bi, Qian Wang, et al.
Bioprocess and Biosystems Engineering|March 7, 2023
Efficient bio-production of glutaric acid by a metabolically engineered Escherichia coli LQ-1 based on a novel nitrogen source feeding strategyWenwen Bi, Chen Chen, Tiantian Wang, et al.
Sensors (Basel, Switzerland)|May 28, 2022
Rapid Optical Biosensing of SARS-CoV-2 Spike Proteins in Artificial SamplesYing Tao, Sumin Bian, Pengbo Wang, et al.
Journal of Virology|April 24, 2015
Nonneutralizing Antibodies Induced by the HIV-1 gp41 NHR Domain Gain Neutralizing Activity in the Presence of the HIV Fusion Inhibitor Enfuvirtide: a Potential Therapeutic Vaccine StrategyQian Wang, Wenwen Bi, Xiaojie Zhu, et al.
Cell Reports. Medicine|February 10, 2024
An enhanced broad-spectrum peptide inhibits Omicron variants in vivoWenwen Bi, Kaiming Tang, Guilin Chen, et al.
Optics Express|October 7, 2021
Wavelength-switchable ultra-narrow linewidth fiber laser enabled by a figure-8 compound-ring-cavity filter and a polarization-managed four-channel filterTing Feng, Da Wei, Wenwen Bi, et al.
Plos Pathogens|December 6, 2019
IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodiesWenwen Bi, Wei Xu, Liang Cheng, et al.
Pageof 2